Latest H3 Biomedicine Inc. Stories
- Company to Present Data on SF3B1 Program at a Symposium During the American Association for Cancer Research Annual Meeting 2014 - CAMBRIDGE, Mass., April 3, 2014 /PRNewswire/ -- H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of precision medicines for oncology, announced today that it has named its lead investigational drug candidate for its program that targets SF3B1, a component of the human genetic splicing machinery that has been...
- To talk saucily.
- Insolent, opprobrious language; impertinent abuse.